Related Experiment Video

Updated: Mar 19, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K

Myocardial salvage and mortality in STEMI: A race against ischemic time

M Rizwan Sardar1, J Dawn Abbott1

  • 1Brown Medical School, Division of Cardiology, Rhode Island Hospital, Providence, Rhode Island.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|June 17, 2016
PubMed

Insights

Total ischemic time (IT) is a better measure of cardiovascular outcomes than door-to-balloon time (DBT) for ST-segment elevation myocardial infarction (STEMI) patients. Adopting IT as a standard metric can improve STEMI healthcare delivery.

Area of Science:

  • Cardiology
  • Healthcare Quality Improvement
  • Clinical Metrics

Background:

  • ST-segment elevation myocardial infarction (STEMI) management relies on timely reperfusion therapies.
  • Door-to-balloon time (DBT) is a commonly used metric, but its predictive value for outcomes is debated.
  • Total ischemic time (IT) represents the duration from coronary artery occlusion to reperfusion.

Discussion:

  • This study evaluates IT and DBT as predictors of cardiovascular outcomes in STEMI.
  • Primary percutaneous coronary intervention (PCI) is the focus of the analysis.
  • IT demonstrates superior predictive capability for infarct size and mortality compared to DBT.

Key Insights:

  • Total ischemic time (IT) is a more robust predictor of cardiovascular outcomes in STEMI patients undergoing primary PCI than door-to-balloon time (DBT).
  • IT better reflects the true duration of myocardial damage.
  • The findings support the clinical significance of IT in assessing STEMI patient prognosis.

Outlook:

  • Adopting IT as a standard quality metric for STEMI care is recommended.
  • Standardization of IT measurement can drive improvements in healthcare delivery systems.
  • Further research may explore IT's role in other acute cardiovascular conditions.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.2K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
408
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
389
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
594
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
310